← Leaderboards
Abdelkarim Gaeldin
Inotek Pharmaceuticals Corporation
$207,325
Attributed
$207,325
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$207,325 · 1
By mechanism
R43$207,325 · 1
Top collaborators
No co-investigators on record.
Most similar at Inotek Pharmaceuticals Corporation
Same institution · by research overlap
- Andrew L Salzman$19,918,828
- Garry John Southan$13,828,224
- Csaba Szabo$15,264,870
- Kanneganti Murthy$5,565,701
- Prakash Jagtap$6,029,479
Others in their field
Top investigators on “Adenosine”
- Chuan He · University Of Chicago$25,386,171
- Raymond C Stevens · University Of Calif-Lawrenc Berkeley Lab$17,634,454
- Joshua A Boyce · Brigham And Women'S Hospital$14,914,539
- Bruce Neil Cronstein · New York University School Of Medicine$14,895,406
- Kazuko Nishikura · University Of Pennsylvania$14,781,272
- Samie R Jaffrey · Weill Medical College Of Cornell Univ$13,696,773
Research focus
AdenosineAntiinflammatory AgentsCytokineDosageDrug Administration RoutesDrug Screening /EvaluationEye AgentEye Disorder ChemotherapyInterleukin 10Laboratory MouseLaboratory RatLigandsNitric Oxide SynthasePurinergic ReceptorReceptor ExpressionUveitis